Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""BLOOD coagulation factors"" wg kryterium: Temat


Tytuł :
[Comparison of Plasma Components between Frozen Plasma and Fresh Frozen Plasma].
Autorzy :
Qin RR; Department of Transfusion, Peking University People's Hospital, , Beijing 100044, China.
Hou RQ; Department of Transfusion, Peking University People's Hospital, Beijing 100044, China,E-mail: .
Yang HY; Department of Transfusion, Peking University People's Hospital, Beijing 100044, China.
Cui YP; Department of Transfusion, Peking University People's Hospital, Beijing 100044, China.
Gao YH; Department of Transfusion, Peking University People's Hospital, Beijing 100044, China.
Tian WQ; Department of Transfusion, Peking University People's Hospital, Beijing 100044, China.
Liu KY; Peking University People's Hospital,Peking University Institute of Hematology, Beijing 100044, China,E-mail:.
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Apr; Vol. 29 (2), pp. 615-619.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation Factors*
Plasma*
Beijing ; Blood Coagulation ; Blood Coagulation Tests ; Humans
Czasopismo naukowe
Tytuł :
The effect of coagulation factors in 2019 novel coronavirus patients: A systematic review and meta-analysis.
Autorzy :
Xiang G; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital Fudan University, Shanghai, China.
Hao S
Fu C
Hu W
Xie L
Wu Q
Li S
Liu X
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Feb 19; Vol. 100 (7), pp. e24537.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Blood Coagulation Factors*
Blood Coagulation Disorders/*virology
COVID-19/*complications
Biomarkers/blood ; Blood Coagulation Disorders/mortality ; COVID-19/mortality ; Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Anticoagulant-related intracranial haemorrhage: time to anticoagulant reversal improving but still slower than thrombolysis for ischaemic stroke.
Autorzy :
Mee HJ; Older Persons Rehabilitation Services, Hutt District Health Board (current work location).
Hanger HC; Older Persons Health, Canterbury District Health Board; Department of Medicine, University of Otago.
Wilkinson TJ; Older Persons Health, Canterbury District Health Board; Department of Medicine, University of Otago.
Beharry JM; Department of Neurology, Christchurch Hospital.
Wu TY; Department of Neurology, Christchurch Hospital; New Zealand Brain Research Institute, Christchurch, New Zealand.
Pokaż więcej
Źródło :
The New Zealand medical journal [N Z Med J] 2021 Feb 05; Vol. 134 (1529), pp. 69-79. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Blood Coagulation Factors/*therapeutic use
Intracranial Hemorrhages/*chemically induced
Intracranial Hemorrhages/*drug therapy
Ischemic Stroke/*drug therapy
Thrombolytic Therapy/*methods
Thrombolytic Therapy/*standards
Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Blood Coagulation Factors/administration & dosage ; Dabigatran/adverse effects ; Female ; Humans ; International Normalized Ratio ; Intracranial Hemorrhages/diagnosis ; Male ; Middle Aged ; New Zealand ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Warfarin/adverse effects
Czasopismo naukowe
Tytuł :
Inhibitor development in mild haemophilia after a major surgery for periampullary cancer (Whipple's procedure) in an elderly man.
Autorzy :
Ganju N; Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
Rajendran J; Department of Gastrointestinal Surgery and Liver Transplant, All India Institute of Medical Sciences, New Delhi, India.
Aggarwal M; Department of Hematology, All India Institute of Medical Sciences, New Delhi, India .
Dash N; Department of Gastrointestinal Surgery and Liver Transplant, All India Institute of Medical Sciences, New Delhi, India.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Jan 29; Vol. 14 (1). Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Blood Coagulation Factors/*antagonists & inhibitors
Hemophilia A/*immunology
Pancreatic Neoplasms/*surgery
Postoperative Hemorrhage/*drug therapy
Aged ; Antibody Formation/immunology ; Blood Coagulation Factors/immunology ; Factor VIII/administration & dosage ; Factor VIII/therapeutic use ; Fatal Outcome ; Hematology/standards ; Hemophilia A/complications ; Humans ; Immunoglobulin Fc Fragments/administration & dosage ; Immunoglobulin Fc Fragments/therapeutic use ; Intracranial Hemorrhages/complications ; Male ; Pancreatic Neoplasms/complications ; Postoperative Complications/epidemiology ; Postoperative Complications/immunology ; Postoperative Hemorrhage/etiology ; Recombinant Fusion Proteins/administration & dosage ; Recombinant Fusion Proteins/therapeutic use ; Risk Factors ; Surgeons/statistics & numerical data
SCR Disease Name :
Pancreatic Carcinoma
Czasopismo naukowe
Tytuł :
Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation.
Autorzy :
Gavriilaki E; Hematology Department-BMT Unit, G Papanicolaou Hospital, 57010 Thessaloniki, Greece.; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
Sakellari I; Hematology Department-BMT Unit, G Papanicolaou Hospital, 57010 Thessaloniki, Greece.
Anyfanti P; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
Batsis I; Hematology Department-BMT Unit, G Papanicolaou Hospital, 57010 Thessaloniki, Greece.
Vardi A; Hematology Department-BMT Unit, G Papanicolaou Hospital, 57010 Thessaloniki, Greece.
Bousiou Z; Hematology Department-BMT Unit, G Papanicolaou Hospital, 57010 Thessaloniki, Greece.
Lazaridis A; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
Nikolaidou B; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
Zarifis I; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
Masmanidou M; Hematology Department-BMT Unit, G Papanicolaou Hospital, 57010 Thessaloniki, Greece.
Yiannaki E; Hematology Laboratory, Theagenion Cancer Center, 54007 Thessaloniki, Greece.
Markala D; Hematology Laboratory, Theagenion Cancer Center, 54007 Thessaloniki, Greece.
Anagnostopoulos A; Hematology Department-BMT Unit, G Papanicolaou Hospital, 57010 Thessaloniki, Greece.
Douma S; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
Gkaliagkousi E; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, 56403 Thessaloniki, Greece.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Dec 21; Vol. 21 (24). Date of Electronic Publication: 2020 Dec 21.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation Factors*
Cardiovascular Diseases/*diagnosis
Cell-Derived Microparticles/*pathology
Endothelium, Vascular/*injuries
Graft vs Host Disease/*etiology
Hematologic Neoplasms/*therapy
Hematopoietic Stem Cell Transplantation/*adverse effects
Adolescent ; Adult ; Cancer Survivors/statistics & numerical data ; Cardiovascular Diseases/etiology ; Case-Control Studies ; Female ; Graft vs Host Disease/pathology ; Heart Disease Risk Factors ; Humans ; Male ; Middle Aged ; Transplantation, Homologous ; Young Adult
Czasopismo naukowe
Tytuł :
Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
Autorzy :
Nascimento Conde J; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.
Schutt WR; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.
Gorbunova EE; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.
Mackow ER; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA .
Pokaż więcej
Źródło :
MBio [mBio] 2020 Dec 11; Vol. 11 (6). Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Coagulation Factors*
Inflammation*
Endothelial Cells/*virology
Peptidyl-Dipeptidase A/*genetics
SARS-CoV-2/*pathogenicity
Animals ; Cells, Cultured ; Chlorocebus aethiops ; Endothelial Cells/immunology ; Endothelial Cells/pathology ; Humans ; Recombinant Proteins ; Vero Cells
Czasopismo naukowe
Tytuł :
Emergent reversal of oral factor Xa inhibitors with four-factor prothrombin complex concentrate.
Autorzy :
Lipari L; Department of Pharmacy, Research Medical Center, Kansas City, MO, USA. Electronic address: .
Yang S; Department of Anesthesiology, Saint Luke's Health System, Kansas City, MO, USA. Electronic address: .
Milligan B; Department of Neurosurgery, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: .
Blunck J; Department of Pharmacy, Saint Luke's Health System, Kansas City, MO, USA. Electronic address: .
Pokaż więcej
Źródło :
The American journal of emergency medicine [Am J Emerg Med] 2020 Dec; Vol. 38 (12), pp. 2641-2645. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Blood Coagulation Factors/*therapeutic use
Factor Xa Inhibitors/*adverse effects
Hemorrhage/*therapy
Thromboembolism/*chemically induced
Aged ; Aged, 80 and over ; Antidotes/economics ; Blood Coagulation Factors/economics ; Drug Costs ; Emergencies ; Factor Xa/economics ; Female ; Gastrointestinal Hemorrhage/chemically induced ; Gastrointestinal Hemorrhage/therapy ; Hemorrhage/chemically induced ; Hospital Mortality ; Humans ; Intracranial Hemorrhages/chemically induced ; Intracranial Hemorrhages/therapy ; Male ; Pyrazoles/adverse effects ; Pyridones/adverse effects ; Recombinant Proteins/economics ; Rivaroxaban/adverse effects ; Thromboembolism/epidemiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Colloid Transfusion, Natural Anticoagulant Depletion, and Symmetric Peripheral Gangrene.
Autorzy :
Warkentin TE; McMaster University, Hamilton, ON, Canada .
Ning S; McMaster University, Hamilton, ON, Canada .
Lim W; McMaster University, Hamilton, ON, Canada .
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Oct 15; Vol. 383 (16), pp. 1592-1594.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Blood Coagulation Factors*
Albumins/*adverse effects
Colloids/*adverse effects
Gangrene/*etiology
Shock, Septic/*complications
Adult ; Blood Transfusion ; Colloids/administration & dosage ; Critical Illness ; Disseminated Intravascular Coagulation/complications ; Female ; Humans ; Middle Aged ; Shock, Septic/therapy
Raport
Tytuł :
Multi-centered evaluation of a novel fixed-dose four-factor prothrombin complex concentrate protocol for warfarin reversal.
Autorzy :
Dietrich SK; University of Colorado Health- North, Department of Pharmacy, Fort Collins, CO, United States of America. Electronic address: .
Mixon M; University of Colorado Health- North, Department of Pharmacy, Fort Collins, CO, United States of America.
Holowatyj M; University of Colorado Health- South, Department of Pharmacy, Colorado Springs, CO, United States of America.
Werth JC; University of Colorado Health- North, Department of Pharmacy, Fort Collins, CO, United States of America.
Delgado SA; University of Colorado Health- North, Department of Pharmacy, Fort Collins, CO, United States of America.
Mascolo NE; University of Colorado Health- North, Department of Pharmacy, Fort Collins, CO, United States of America.
Meister ER; University of Colorado Health- North, Department of Pharmacy, Fort Collins, CO, United States of America.
Zoucha SM; University of Colorado Health- North, Department of Pharmacy, Fort Collins, CO, United States of America.
Trujillo TC; University of Colorado Health, Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, United States of America.
Pokaż więcej
Źródło :
The American journal of emergency medicine [Am J Emerg Med] 2020 Oct; Vol. 38 (10), pp. 2096-2100. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Blood Coagulation Factors/*therapeutic use
Hemorrhage/*drug therapy
Warfarin/*antagonists & inhibitors
Aged ; Aged, 80 and over ; Blood Coagulation Factors/pharmacology ; Chi-Square Distribution ; Female ; Gastrointestinal Hemorrhage/drug therapy ; Gastrointestinal Hemorrhage/physiopathology ; Hemorrhage/physiopathology ; Humans ; Intracranial Hemorrhages/drug therapy ; Intracranial Hemorrhages/physiopathology ; Male ; Middle Aged ; Warfarin/adverse effects ; Warfarin/therapeutic use
Czasopismo naukowe
Tytuł :
[Perioperative application of recombinant human coagulation factor Ⅶa combined with prothrombin complex in two hemophilia A patients with high titer inhibitor].
Autorzy :
Xu PP; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Zhou H; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Zhang P; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Wang JQ; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Liu L; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Li C; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Li MJ; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Li GP; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Ding BJ; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Liu JP; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Wang XR; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Song YP; Department of Hematology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2020 Sep 14; Vol. 41 (9), pp. 773-775.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation Factors*
Factor VIIa*/therapeutic use
Hemophilia A*/drug therapy
Prothrombin*
Recombinant Proteins*/therapeutic use
Factor VIII ; Humans
Czasopismo naukowe
Tytuł :
Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhage.
Autorzy :
Beynon C; Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. Electronic address: .
Nofal M; Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Rizos T; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Laible M; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Sakowitz OW; Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Unterberg AW; Department of Neurosurgery, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2020 Sep; Vol. 79, pp. 197-202. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation Factors/*therapeutic use
Intracranial Hemorrhage, Traumatic/*drug therapy
Aged ; Anticoagulants/adverse effects ; Blood Coagulation ; Blood Coagulation Factors/administration & dosage ; Female ; Glasgow Coma Scale ; Humans ; Intracranial Hemorrhage, Traumatic/blood ; Intracranial Hemorrhage, Traumatic/pathology ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Differential response to FEIBA is strongly associated with the prothrombotic microparticles.
Autorzy :
Soni P; National Institute of Immunohematology (NIIH-ICMR), 13th floor, KEM Hospital, Parel, Mumbai 400012, India.
Shanmukhaiah C; Department of Hematology, Seth GS Medical College and KEM Hospital, Parel, Mumbai 400012, India.
Patil R; National Institute of Immunohematology (NIIH-ICMR), 13th floor, KEM Hospital, Parel, Mumbai 400012, India.
Shetty S; National Institute of Immunohematology (NIIH-ICMR), 13th floor, KEM Hospital, Parel, Mumbai 400012, India. Electronic address: .
Pokaż więcej
Źródło :
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2020 Sep; Vol. 84, pp. 102441. Date of Electronic Publication: 2020 Apr 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Coagulation/*drug effects
Blood Coagulation Factors/*therapeutic use
Cell-Derived Microparticles/*drug effects
Coagulants/*therapeutic use
Hemophilia A/*drug therapy
Adolescent ; Adult ; Blood Coagulation Factors/adverse effects ; Child ; Coagulants/adverse effects ; Hemophilia A/blood ; Humans ; Thrombosis/chemically induced ; Young Adult
Czasopismo naukowe
Tytuł :
Fixed-Dose 4-Factor Prothrombin Complex Concentrate Administration: In Search of the Optimal Dosing.
Autorzy :
Mishra AK; Postgraduates in Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts.
Sahu KK; Postgraduates in Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts.
John K; Believers Church Medical College, Tiruvalla, India.
Lal A; Department of Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
The Journal of emergency medicine [J Emerg Med] 2020 Aug; Vol. 59 (2), pp. 313-314.
Typ publikacji :
Letter; Comment
MeSH Terms :
Anticoagulants*/adverse effects
Blood Coagulation Factors*/therapeutic use
Humans ; Prospective Studies ; Vitamin K
Opinia redakcyjna
Tytuł :
Reversal strategies and outcomes in patients with atrial fibrillation and warfarin-associated intracranial hemorrhage.
Autorzy :
Singer DE; Division of General Internal Medicine, Massachusetts General Hospital, 100 Cambridge St., 16th Floor, Boston, MA 02114, United States; Harvard Medical School, Boston, MA, United States. Electronic address: .
Borowsky LH; Division of General Internal Medicine, Massachusetts General Hospital, 100 Cambridge St., 16th Floor, Boston, MA 02114, United States. Electronic address: .
Regan S; Division of General Internal Medicine, Massachusetts General Hospital, 100 Cambridge St., 16th Floor, Boston, MA 02114, United States; Harvard Medical School, Boston, MA, United States. Electronic address: .
Lee JW; Harvard Medical School, Boston, MA, United States; Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States. Electronic address: .
Zint K; Boehringer Ingelheim, International GmbH, Ingelheim, Germany. Electronic address: .
Franca LR; Boehringer Ingelheim, International GmbH, Ingelheim, Germany. Electronic address: .
Goldstein JN; Harvard Medical School, Boston, MA, United States; Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, United States. Electronic address: .
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2020 Aug; Vol. 29 (8), pp. 104903. Date of Electronic Publication: 2020 May 24.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Plasma*
Anticoagulants/*adverse effects
Atrial Fibrillation/*drug therapy
Blood Coagulation/*drug effects
Blood Coagulation Factors/*therapeutic use
Coagulants/*therapeutic use
Factor VIIa/*therapeutic use
Intracranial Hemorrhages/*therapy
Warfarin/*adverse effects
Aged ; Aged, 80 and over ; Atrial Fibrillation/diagnosis ; Blood Coagulation Factors/adverse effects ; Boston ; Coagulants/adverse effects ; Factor VIIa/adverse effects ; Female ; Humans ; International Normalized Ratio ; Intracranial Hemorrhages/chemically induced ; Intracranial Hemorrhages/diagnosis ; Male ; Retrospective Studies ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding.
Autorzy :
Sheikh-Taha M; Department of Pharmacy Practice, Lebanese American University, Byblos, Lebanon. .; Department of Pharmacy, Huntsville Hospital, Huntsville, AL, USA. .
Crawley RM; Department of Pharmacy, Huntsville Hospital, Huntsville, AL, USA.
Pokaż więcej
Źródło :
American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2020 Jun; Vol. 20 (3), pp. 295-299.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation Factors*/administration & dosage
Blood Coagulation Factors*/adverse effects
Blood Coagulation Factors*/pharmacokinetics
Gastrointestinal Hemorrhage*/blood
Gastrointestinal Hemorrhage*/chemically induced
Gastrointestinal Hemorrhage*/drug therapy
Gastrointestinal Hemorrhage*/mortality
Intracranial Hemorrhages*/blood
Intracranial Hemorrhages*/chemically induced
Intracranial Hemorrhages*/drug therapy
Intracranial Hemorrhages*/mortality
Blood Coagulation/*drug effects
Pyrazoles/*adverse effects
Pyridones/*adverse effects
Rivaroxaban/*adverse effects
Aged ; Antidotes/administration & dosage ; Antidotes/adverse effects ; Antidotes/pharmacokinetics ; Factor Xa Inhibitors/adverse effects ; Female ; Hemostasis/drug effects ; Humans ; Male ; Outcome and Process Assessment, Health Care ; Retrospective Studies ; Survival Analysis ; Thrombosis/diagnosis ; Thrombosis/etiology ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Effects of rivaroxaban and dabigatran on local expression of coagulation and inflammatory factors within human aortic stenotic valves.
Autorzy :
Wypasek E; John Paul II Hospital, Cracow, Poland; Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Cracow University, Cracow, Poland. Electronic address: .
Natorska J; John Paul II Hospital, Cracow, Poland; Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland.
Mazur P; John Paul II Hospital, Cracow, Poland; Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland.
Kopytek M; John Paul II Hospital, Cracow, Poland; Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland.
Gawęda B; Division of Cardiovascular Surgery, St. Jadwiga Provincial Clinical Hospital, Rzeszow, Poland.
Kapusta P; John Paul II Hospital, Cracow, Poland.
Madeja J; John Paul II Hospital, Cracow, Poland.
Iwaniec T; Department of Hematology, Jagiellonian University, Krakow, Poland.
Kapelak B; John Paul II Hospital, Cracow, Poland; Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland.
Undas A; John Paul II Hospital, Cracow, Poland; Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland.
Pokaż więcej
Źródło :
Vascular pharmacology [Vascul Pharmacol] 2020 Jul; Vol. 130, pp. 106679. Date of Electronic Publication: 2020 May 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antithrombins/*pharmacology
Aortic Valve/*drug effects
Aortic Valve Stenosis/*drug therapy
Blood Coagulation Factors/*metabolism
Dabigatran/*pharmacology
Factor Xa Inhibitors/*pharmacology
Inflammation Mediators/*metabolism
Rivaroxaban/*pharmacology
Aged ; Aortic Valve/metabolism ; Aortic Valve/pathology ; Aortic Valve Stenosis/genetics ; Aortic Valve Stenosis/metabolism ; Aortic Valve Stenosis/pathology ; Blood Coagulation Factors/genetics ; Cells, Cultured ; Female ; Humans ; Male ; Middle Aged ; Severity of Illness Index ; Signal Transduction
Czasopismo naukowe
Tytuł :
Intraosseous administration of 4-factor prothrombin complex concentrate prior to emergent surgery after receiving apixaban.
Autorzy :
Ratliff P; Department of Pharmacy Services, Saint Joseph Hospital, Lexington, KY, USA.
Nutley K; Department of Pharmacy Services, Saint Joseph Hospital, Lexington, KY, USA.
Schroeder W; Department of Pharmacy Services, Saint Joseph Hospital, Lexington, KY, USA.
Cottingham L; Department of Pharmacy Services, Saint Joseph Hospital, Lexington, KY, USA.
Pokaż więcej
Źródło :
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2020 Jun; Vol. 45 (3), pp. 577-579. Date of Electronic Publication: 2019 Dec 05.
Typ publikacji :
Case Reports
MeSH Terms :
Hemostasis*
Blood Coagulation Factors/*therapeutic use
Factor Xa Inhibitors/*therapeutic use
Pyrazoles/*therapeutic use
Pyridones/*therapeutic use
Aged ; Blood Coagulation Factors/administration & dosage ; Factor Xa Inhibitors/administration & dosage ; Female ; Humans ; Preoperative Period ; Pyrazoles/administration & dosage ; Pyridones/administration & dosage
Raport
Tytuł :
The hematology laboratory's response to the COVID-19 pandemic: A scoping review.
Autorzy :
Bell R; Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.
Zini G; Fondazione Policlinico Universitario A. Gemelli IRCCS - Roma, Rome, Italy.; Università Cattolica del Sacro Cuore, Rome, Italy.
d'Onofrio G; Università Cattolica del Sacro Cuore, Rome, Italy.
Rogers HJ; Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Lee YS; Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.
Frater JL; Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2021 Apr; Vol. 43 (2), pp. 148-159. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Pandemics*
COVID-19/*diagnosis
COVID-19/*epidemiology
Hematology/*methods
Laboratories/*organization & administration
Bibliometrics ; Biomarkers/blood ; Blood Cell Count ; Blood Coagulation Factors/metabolism ; Blood Coagulation Tests ; COVID-19/blood ; COVID-19/virology ; China/epidemiology ; Europe/epidemiology ; Fibrin Fibrinogen Degradation Products/metabolism ; Hematology/instrumentation ; Humans ; Prognosis ; Retrospective Studies ; SARS-CoV-2/pathogenicity ; Severity of Illness Index ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Protease-activated receptor 1 as a potential therapeutic target for COVID-19.
Autorzy :
Rovai ES; Department of Dentistry, University of Taubate, Taubate 12010-490, Brazil.
Alves T; Division of Periodontics, Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo 05508-000, Brazil.
Holzhausen M; Division of Periodontics, Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo 05508-000, Brazil.
Pokaż więcej
Źródło :
Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2021 Mar; Vol. 246 (6), pp. 688-694. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Blood Coagulation/*physiology
COVID-19/*pathology
Disseminated Intravascular Coagulation/*pathology
Receptor, PAR-1/*metabolism
Thrombin/*metabolism
Anticoagulants/therapeutic use ; Blood Coagulation/drug effects ; Blood Coagulation Factors/metabolism ; COVID-19/drug therapy ; Disseminated Intravascular Coagulation/drug therapy ; Humans ; Pulmonary Embolism/pathology ; Pulmonary Embolism/prevention & control ; Receptor, PAR-1/antagonists & inhibitors ; Receptors, Cell Surface/metabolism ; SARS-CoV-2 ; Venous Thrombosis/pathology ; Venous Thrombosis/prevention & control
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
Thromboelastometry-guided anticoagulation reversal in a patient with ventricular assist device with intracranial hemorrhage.
Autorzy :
Bonderski VA; Department of Pharmacy, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, United States. Electronic address: .
Portillo J; Department of Emergency Medicine, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, United States. Electronic address: .
Sharp L; Department of Emergency Medicine, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, United States. Electronic address: .
Rech MA; Department of Emergency Medicine, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, United States. Electronic address: .
Pokaż więcej
Źródło :
The American journal of emergency medicine [Am J Emerg Med] 2021 Mar; Vol. 41, pp. 265.e5-265.e8. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anticoagulants*
Thrombelastography*
Blood Coagulation Factors/*therapeutic use
Heart-Assist Devices/*adverse effects
Intracranial Hemorrhages/*drug therapy
Intracranial Hemorrhages/*etiology
Warfarin/*antagonists & inhibitors
Adult ; Humans ; Male
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies